Sensitivity pattern and beta-lactamase production in clinical isolates of Aeromonas strains

Journal of the Pakistan Medical Association

Volumn 48, Issue 6, 1998, Pages 158-161

  Ahmed, Altaf ^a   Hafiz, Saleem ^a   Ahmed, Qazi Touseef ^b   Majeed, Hina ^b   Syed, Serajuddaula ^b  

^a ZIAUDDIN MEDICAL UNIVERSITY   (Pakistan)

^b KARACHI MEDICAL AND DENTAL COLLEGE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; THIENAMYCIN DERIVATIVE;

AEROMONAS; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; ENZYMOLOGY; GRAM NEGATIVE INFECTION; HUMAN; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PAKISTAN; PENICILLIN RESISTANCE;

AEROMONAS; AMPICILLIN RESISTANCE; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFOTAXIME; CEPHALOSPORINS; CHLORAMPHENICOL; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; PAKISTAN; THIENAMYCINS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0032093181     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hazen TC, Filtermans CB, Hirsch RP et al. Prevalence and distribution of Aeromonas hydrophila in the United States. App. Environ. Microbiol., 1978;36:731-738.
2. Parveen S, Isla, MS and Huq A. Abundance of Aeromonas spp. in River and lake waters in and around Dhaka, Bangladesh. J. Diarrhoeal. Dis., 1995;13:183-186.
3. Janda JM and Duffey PS. Mesophilic aeromonads in human disease: Current taxonomy, laboratory identification and infectious disease spectrum. Rev. Infect. Dis., 1988;10:980-997.
4. Harris RL, Fainstein V, Ehing L et al. Bacteraemia caused by Aeromonas species in hospitalized cancer patients. Rev. Infect. dis., 1985;7:314-320.
5. Janda JM and Brenden R. Importance of Aeromonas sobria in Aeromonas bacteraemia. J. Infect Dis., 1987;155:589-591.
6. Joseph SW, Carnahan AM, Brayton PR et al. Aeromonas jandaei and Aeromonas veronii dual infection of a human wound following aquatic exposure, J. Clin. Microbiol., 1991;29:565-569.
7. Isaac RD. Wound infection with aerogenic aeromonas strains. A review of twenty seven cases. Eur. J. Clin. Microbiol., Infect Dis., 1988;7:355-360.
8. McCracken AW and Barely R. Isolation of Aeromonas species from clinical sources. J. Clin. Pathol., 1972;25:970-975.
9. Bauer AW, Kirby WMM, Sheris JC et al. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol., 1966;45:493-496.
10. Tu KK, Jorgensen JH and Stratton CW. A rapid paper disc test for penicillinase. Am. J. Clin. Pathol., 1981;75:557-559.
11. Citron DM, Ostavari MI, Karlsson A et al. Evaluation of the Epsilometer (E test) for susceptibility testing of anaerobic bacteria. J. Clin. Microbiol., 1991;29:2197-2203.
12. Brown DFJ, Brown L. Evaluation of the E test, a novel method of quantifying antimicrobial activity. J. Antimicrob chemother., 1991;27:185-190.
13. Baker CN, Stocker SA, Culver DH et al. Comparision of the E test to Agar Dilution, Broth Microdilution and Agar diffusion susceptibility testing techniques by using a special challlenge set of bacteria. J. Clin. Microbiol., 1991;29:533-538.
14. Glupczynski Y, Labbe M, Hansen W et al. Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J. Clin. Microbiol., 1991;29:2072-2075.
15. Jorgensen JH, Howell AW, Maher LA. Quantitative antimicrobial susceptibility testing of Haemophilus inflenzae and streptococcus pneumoniae by using the E test. J. Clin.Microbiol., 1991;29:109-114.
16. Fass RJ and Barnishan J. In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents. Antimicrob. Agents Chemother., 1981;19:357-358.
17. Agger WA, McCormick JD Gurwith MJ. Clinical and microbiological features of Aeromonas hydrophilia-associated diarrhoea. J. Clin. Microbiol., 1985;21:909-913.
18. Overman TL. Antimicrobial susceptibility of Aeromonas hydrophila. Antimicrob. Agents Chemother., 1980;17:612-614.
19. Kuijper E.J., Peeters, M.F., Schoenmakers, B.S.C. et al. Antimicrobial susceptibility of sixty human faecal isolates of Aeromonas spp. Eur.J. Clin. Microbiol. Infect. Dis., 1989;8:248-250.
20. Burgos A, Quinotos G, Martinez R. et al. In vitro susceptibility of Aeromonas caviae. Aeromonas hydrophila and Aeromonas sobria to fifteen antibacterial agents. Eur. J. Clin. Microbiol. Infect Dis., 1990;9:413-417.
21. Motyl MR, McKinley G, Janda JM. In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria and Aeromonas caviae to 22 antimicrobial agents. Antimicrob. Agents Chemother., 1985;28:151-153.
22. Bakken JS, Sanders CC, Clark RB et al. Beta Lactam resistance in Aeromonas spp. caused by induicible Beta Lactamases active against pencillins, cephalosporins and carbapenems. Antimicrob. Agents Chemother. 1988;32:1314-1319.
23. Cheng AFB, Ling TKW, Lam AW et al. The antimicrobial activity and Beta-Lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents. J. Antimicrob. Chemother., 1993;31:699-709.
24. Chang BJ, Bolton N. Plasmids and resistance to antimicrobial agents in Aeromonas sobria and Aeromonas hydrophila clinical isolates. Antimicrob. Agents Chemother., 1987;31:1081-1089.
25. Bhatnagar S, Bhan MK, Saazawal S et al. Efficacy of massive dose oral gentamicin therapy in non-bloody persistent diarrhoea with associated malnutrition. J. Paediatr. Gastroenterol. Nutr., 1992;15:117-124.
26. Bhan MK, Arora NK, Khoshoo V et al. Chronic diarrhoea in infant and children. Indian. J. Paediatr., 1985;52:483-495.
27. Bartlett, A. V., Torun, B., Morales, C. et al. Oral gentamicin is not effective treatment for persistent diarrhoea. Acta Paediatr. (Suppl) 1992;381:149-154.
28. DuPont, H.L. Diarrhoeal disease: Current concepts and future challenges. Antimicrobial therapy and prophylaxis. Trans. R. Soc. Trop. Med. Hyg., 1993;87:(Suppl 3):31-34.